Karyopharm Therapeutics Inc.

1.19 USD
+0.00 (+0.42%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Karyopharm Therapeutics Inc. stock is up 14.42% since 30 days ago. The next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 10 March’s closed higher than February.

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company has license agreement with Menarini Group to develop and commercialize NEXPOVIO for human oncology indications in Europe, including the United Kingdom; Latin America; and other countries.